Oscar Health, Inc. $OSCR Shares Bought by BIT Capital GmbH

BIT Capital GmbH lifted its position in Oscar Health, Inc. (NYSE:OSCR) by 545.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,186,267 shares of the company’s stock after acquiring an additional 5,227,152 shares during the quarter. Oscar Health accounts for approximately 3.3% of BIT Capital GmbH’s holdings, making the stock its 12th largest position. BIT Capital GmbH’s holdings in Oscar Health were worth $88,897,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in OSCR. Strs Ohio acquired a new position in shares of Oscar Health in the 1st quarter worth approximately $30,000. Jones Financial Companies Lllp lifted its holdings in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after acquiring an additional 2,242 shares during the last quarter. Quarry LP lifted its holdings in Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after acquiring an additional 1,469 shares during the last quarter. Fifth Third Bancorp lifted its holdings in Oscar Health by 148.7% in the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after acquiring an additional 1,413 shares during the last quarter. Finally, Binnacle Investments Inc bought a new position in Oscar Health in the second quarter worth about $75,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Insider Activity at Oscar Health

In related news, insider Janet Liang sold 12,475 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $273,701.50. Following the sale, the insider owned 259,057 shares of the company’s stock, valued at $5,683,710.58. The trade was a 4.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 34,120 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total transaction of $748,592.80. Following the completion of the transaction, the director owned 480,866 shares in the company, valued at approximately $10,550,200.04. This trade represents a 6.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders have sold 189,660 shares of company stock worth $4,283,140. Insiders own 24.39% of the company’s stock.

Oscar Health News Roundup

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: Wells Fargo upgraded Oscar Health from “strong sell” to “hold”, easing bearish sentiment even though its $20 target remains below the current share price. Zacks.com
• Positive Sentiment: Oscar Health’s recent earnings showed a major EPS beat, which supports the stock’s fundamental story despite revenue coming in below estimates.
• Neutral Sentiment: A company co-founder shifting into an advisory leadership role looks like an internal reorganization rather than a disruptive change. Oscar Health Co-Founder Shifts to Advisory Leadership Role
• Neutral Sentiment: Multiple insiders, including CFO Richard Scott Blackley and CAO Victoria Baltrus, sold shares under pre-planned 10b5-1 programs to cover tax obligations on vested equity awards, which is less concerning than discretionary selling.
• Negative Sentiment: Director Mario Schlosser sold 34,120 shares, the largest insider sale in the latest batch, which may pressure sentiment even though it was pre-arranged.

Analysts Set New Price Targets

A number of research firms have recently weighed in on OSCR. Wells Fargo & Company set a $20.00 price target on Oscar Health and gave the company an “equal weight” rating in a report on Thursday. Raymond James Financial raised Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price target on the stock in a report on Thursday, February 12th. Wall Street Zen cut Oscar Health from a “strong-buy” rating to a “buy” rating in a report on Saturday. Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a research note on Tuesday, April 21st. Finally, Robert W. Baird lifted their price target on shares of Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Oscar Health has an average rating of “Hold” and an average target price of $20.22.

Oscar Health Stock Up 4.2%

OSCR stock opened at $24.59 on Friday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 1 year low of $10.69 and a 1 year high of $25.58. The company has a fifty day simple moving average of $18.39 and a 200 day simple moving average of $16.06. The firm has a market cap of $7.41 billion, a PE ratio of -41.68, a PEG ratio of 1.65 and a beta of 2.37.

Oscar Health (NYSE:OSCR) last released its earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The firm had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. During the same quarter in the previous year, the business earned $0.92 EPS. The business’s revenue was up 52.6% on a year-over-year basis. Sell-side analysts anticipate that Oscar Health, Inc. will post 0.47 EPS for the current fiscal year.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.